Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T08:00:02.289Z Has data issue: false hasContentIssue false

The Covert Administration of Medications: Legal and Ethical Complexities for Health Care Professionals

Published online by Cambridge University Press:  01 January 2021

Abstract

The practice of covertly administering medications to patients without their consent is often discussed in the framework of legal questions around the right of patients to consent and refuse medical treatment. However, this practice also raises significant questions surrounding the professional duties and obligations of health care professionals as it relates to the decision-making process of whether to engage in the covert administration of medications. In this paper, I present an overview of the origin of those duties and obligations, and discuss how those duties and obligations when seen from different perspectives may either justify or prohibit the practice. Further, I discuss whether the duties and obligations of health care professionals as they are currently framed are suited to address the complexities of this issue both from the health care professional and patient perspectives. This analysis is conducted in the context of duties and obligations that arise from not only legal framework but also from the ethical requirements from professional codes of ethics.

Type
Symposium Articles
Copyright
Copyright © American Society of Law, Medicine and Ethics 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Treloar, A., Philpot, M., and Beats, B., “Concealing Medication in Patients' Food,” The Lancet: Viewpoint 357 (January 6, 2001): 62, at 62.CrossRefGoogle Scholar
World Health Organization, Genomics, available at <http://www.who.int/genomics/public/patientrights/en/> (last visited May 1, 2017).+(last+visited+May+1,+2017).>Google Scholar
Supra note 2.Google Scholar
Haw, C. and Stubbs, J., “Administration of Medicines in Food and Drink: A Study of Older Inpatients with Severe Mental Illness,” International Psychogeriatrics 22, no. 3 (2010): 409-416; C. Haw and J. Stubbs, “Covert Administration of Medications to Older Adults: A Review of the Literature and Published Studies,” Journal of Psychiatric and Mental Health Nursing 17 (2010): 761-768.Google Scholar
Northamptonshire Healthcare (“NHS Foundation Trust”), “Covert Administration of Medicines Policy and Guidelines,” at 4, available at <http://www.nht.nhs.uk/mediaFiles/downloads/19002227/MMP015%20-%20Covert%20administration%20of%20medicines%20(June15-June17).pdf> (last visited May 1, 2017).+(last+visited+May+1,+2017).>Google Scholar
Mental Health Commission for Scotland, Good Practice Guide: Covert Medication, available at <http://www.mwc-scot.org.uk/media/140485/covert_medication_finalnov_13.pdf> (last visited May 1, 2017).+(last+visited+May+1,+2017).>Google Scholar
Treloar, A., Beats, B., and Philpot, M., “A Pill in the Sandwich: Covert Medication in Food and Drink,” Journal of the Royal Society of Medicine 93, no. 8 (2000): 408–11.CrossRefGoogle Scholar
Elvish, R., James, I., and Milne, D., “Lying in Dementia Care: An Example of a Culture That Deceives in People's Best Interest,” Aging & Mental Health 14, no. 3 (April 2010): 255-262.Google Scholar
Elvish, James and Milne, supra note 8.Google Scholar
Haw, C. and Stubbs, J., “Covert Administration of Medications to Older Adults: A Review of the Literature and Published Articles,” Journal of Psychiatric and Mental Health Nursing 17, no 9 (2010): 761.Google Scholar
See Haw and Stubbs, supra note 10.Google Scholar
Id. See also, Treloar, Philpot, and Beats, supra note 1, where the authors argue that the practice of covert medications is often carried out in secrecy which result is health care staff failing to discuss the issue with others, which can give rise to patient abuse.Google Scholar
Mental Welfare Commission for Scotland, available at <http://www.mwcscot.org.uk/media/140485/covert_medication_finalnov_13.pdf> (last visited May 1, 2017).+(last+visited+May+1,+2017).>Google Scholar
Supra note 14.Google Scholar
Northamptonshire Healthcare (“NHS Foundation Trust”), “Covert Administration of Medicines Policy and Guidelines,” available at <http://www.nht.nhs.uk/mediaFiles/downloads/19002227/MMP015%20-%20Covert%20administration%20of%20medicines%20(June15-June17)pdf> (last visited May 3, 2017).+(last+visited+May+3,+2017).>Google Scholar
Kirkevold, O. and Engedal, K., “Concealment of Drugs in Food and Beverages in Nursing Homes: Cross Sectional Study,” British Medical Journal 330, no. 20 (2004). 1-4Google Scholar
See for example, Health Care Consent Act, 1996, S.O. 1996, c.2, Sch.A., s. 4(1); Hospitals Act, R.S.N.S. 1989, c. 208.Google Scholar
Ciarlariello v. Schacter, [1993] 2 S.C.R. 119 at para. 135.Google Scholar
R. v. Big M Drug Mart Ltd., [1985] 1 S.C.R. 295 at 346.Google Scholar
Fleming v. Reid (1991), 4 O.R. (3d) 74 (C.A.).Google Scholar
Charter of Rights and Freedoms, Part I of the Constitution Act, 1982, being Schedule B to the Canada Act 1982 (U.K.), 1982, c. 11.Google Scholar
Fleming v. Reid (1991), 4 O.R. (3d) 74 (C.A.).Google Scholar
Ciarlariello v. Schacter, [1993] 2 S.C.R. 119.Google Scholar
Supra note 25, at 133.Google Scholar
Rodriguez v. British Columbia (Attorney General), [1993] 3 S.C.R. 519.Google Scholar
Supra note 27, at 618.Google Scholar
Starson v. Swayze, [2003] 1 S.C.R. 722, 2003 SCC 32.Google Scholar
Carter v. Canada (Attorney General) 2015 SCC 5, [2015] 1 S.C.R. 331.Google Scholar
Supra note 30, at para. 67.Google Scholar
See for example, Health Care Consent Act, 1996, S.O. 1996, c. 2, Sched. A; Hospitals Act, R.S.N.S 1989, c. 208; Health Care (Consent) and Care Facility (Admission) Act, RSBC 1996, c 181.Google Scholar
Health and Disability Commissioner (Code of Health and Disability Services Consumers' Rights) Regulations 1996, the Right number 7 of the Code is the right to make an informed choice and give informed consent.Google Scholar
Patient's Rights Act, 1996. Section 13A requires that no medical care shall be given unless and until the patient has given his informed consent to it.Google Scholar
Zimring, S., “Health Care Decision-Making Capacity: A Legal Perspective for Long-Term Care Providers” Journal of the American Medical Directors Association 7, no 5 (June 2006): 322-326.Google Scholar
Hawaii Revised Statutes, Div. 1, Title 19, Ch.327-E7.Google Scholar
Oregon Revised Statutes, Title 13, Ch. 677.507.Google Scholar
Texas Health and Safety Code, Title 2, Subtitle H, Ch. 166, ss.166.045-166.046.Google Scholar
Aintree University Hospitals NHS Foundation Trust v. James, [2013] UKSC 67.Google Scholar
Supra note 39 at paras. 19 to 23.Google Scholar
Hospitals Act, RSNS 1989 c. 208, section 54(2).Google Scholar
Northamptonshire Healthcare (“NHS Foundation Trust”), supra note 17.Google Scholar
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. NICE is an executive non-departmental public body, sponsored by the UK Department of Health.Google Scholar
NICE Medicine Management in Care Homes, Quality Standard [QS85], Published March 2015, available at <https://www.nice.org.uk/guidance/qs85/chapter/quality-statement-6-covert-medicines-administration> (last visited May 3, 2017).+(last+visited+May+3,+2017).>Google Scholar
NICE Medicine Management in Care Homes, supra note 44.Google Scholar
Mental Health Commission for Scotland. Good Practice Guide: Covert Medication, available at <http://www.mwc-scot.org.uk/media/140485/covert_medication_finalnov_13.pdf> (last visited May 3, 2017).+(last+visited+May+3,+2017).>Google Scholar
The Royal College of Psychiatrists, “College Statement on Covert Administration of Medications.” The Psychiatrist, available at <http://www.rcpsych.ac.uk/pdf/covertmedicine.full.pdf> (last visited May 3, 2017).+(last+visited+May+3,+2017).>Google Scholar
The Royal College of Psychiatrists, supra note 47.Google Scholar
Canadian Nurses Association, Code of Ethics for Registered Nurses, 2008 Centennial edition, available at <https://www.cna-aiic.ca/~/media/cna/files/en/codeofethics.pdf> (last visited May 3, 2017)+(last+visited+May+3,+2017)>Google Scholar
Haw and Stubbs, supra note 10, at 763.Google Scholar
See supra note 18Google Scholar
Canadian Nurses Association, supra note 49.Google Scholar
College Registered Nurses Nova Scotia, 2015, (Revised), Medication Guidelines for Registered Nurses, available at. <https://crnns.ca/wp-content/uploads/2015/05/Medication-Guidelines.pdf> at 30 (last visited May 3, 2017).+at+30+(last+visited+May+3,+2017).>Google Scholar
College Registered Nurses Nova Scotia, supra note 54.Google Scholar
The NMC is the nursing and midwifery regulator for England, Wales, Scotland, Northern Ireland and the Islands.Google Scholar
College of Registered Nurses of Nova Scotia, supra note 54.Google Scholar
College of Registered Psychiatric Nurses of British Columbia, “Evidence Based Guidelines: Dose Form Modification of Medications,” (2011), available at. <http://www.crpnbc.ca/wp-content/uploads/2011/07/Dose-Form-Modification-of-Medication_2011October.pdf> at 2 (last visited May 3, 2017).+at+2+(last+visited+May+3,+2017).>Google Scholar
Healthcare (“NHS Foundation Trust”), “Covert Administration of Medicines Policy and Guidelines” available at <http://www.nht.nhs.uk/mediaFiles/downloads/19002227/MMP015%20-%20Covert%20administration%20of%20medicines%20(June15-June17).pdf> at 6 (last visited May 3, 2017).+at+6+(last+visited+May+3,+2017).>Google Scholar
NHS Foundation Trust, supra note 62, at 6.Google Scholar
Id., at 8, 9.Google Scholar
Eckman, O., Telling Lies: Clues to Deceit in the Marketplace, Politics and Marriage (New York: Norton, 1985).Google Scholar
Elvish, R., James, I., and Milne, D., “Lying in Dementia care: An Example of a Culture that Deceives in People's Best Interest,” Aging & Mental Health 14, no. 3 (April 2010): 255-262, at 255.Google Scholar
Elvish, , James, , and Milne, , supra note 8, at 255.Google Scholar
Erick, K., Hung, D., McNeil, E., and Binder, R. L., “Covert Medication in Psychiatric Emergencies: Is It Ever Ethically Permissable?” Journal of the American Academy of Psychiatry and the Law 40 (2012): 239-245, at 243. See also Srinivasan, T. N. and Thara, R., “At Issue: Management of Medication Noncompliance in Schizophrenia by Families in India,” Schizophrenia Bull 28 (2002): 531-535. Srinivasan and Thara found that patients that subsequently found out that they had been given mediations covertly by their family member had anger and resentment toward the family members who gave the medications covertly.Google Scholar
Teasdale, K. and Kent, G., “The Use of Deception in Nursing,” Journal of Medical Ethics 21, no. 2 (1995): 77-81.Google Scholar
Olsen, D., “Ethical Issues: Putting the Meds in the Apple-sauce,” American Journal of Nursing 112, no. 3 (March 2012) 67-69.Google Scholar
Canadian Nurses Association, supra note 49.Google Scholar
College of Registered Nurses of Manitoba, Interpretative Document: Covert Medications Administration, at 1, available at <https://www.crnm.mb.ca/support/resources> (last visited May 3, 2017).+(last+visited+May+3,+2017).>Google Scholar
College Registered Nurses Nova Scotia, 2015, supra note 54.Google Scholar
College of Registered Nurses of Manitoba, supra note 74, at 1.Google Scholar
College of Registered Nurses of Manitoba, supra note 74.Google Scholar
College of Registered Nurses of Manitoba, supra note 74, at 2.Google Scholar
Treloar et al., supra note 1.Google Scholar
Bok, S., Lying: Moral Choice in Public and Private Life (New York: Vintage Books, 1978).Google Scholar
Olsen, D. P., “Ethical Issues: Putting the Meds in the Apple-sauce,” American Journal of Nursing 112, no. 3 (2012): 67-69.Google Scholar
Haw and Stubbs, supra note 4, at 766.Google Scholar
Treloar et al., supra note 1.Google Scholar